Pharmaceutical Companies

The NMPA approved VELSIPITY in February 2026 for adults with moderately to severely active ulcerative colitis (UC) who had an inadequate response, lost response or were intolerant to conventional therapy or a biologic agent.

It is now integrating those businesses under Asahi Kasei Therapeutics, the name of its existing Japanese pharmaceutical unit.

The deal gives Kyowa Kirin access to Knight’s pan-American commercial infrastructure while allowing Knight to add a targeted oncology therapy to its portfolio.

Sanofi will pay Regeneron US$1 billion upfront, with development, regulatory, and commercial milestones potentially adding another US$ 7 billion.

The Mainz-based biopharmaceutical company said the closures will affect about 1,800 employees at sites in Tübingen, Marburg and Idar-Oberstein.

Profluent will conduct the computational design work using its Profluent Protein Atlas, a dataset containing more than 115 billion unique protein sequences.

Under the partnership, AstraZeneca and UNICEF will train and support 5,000 young people to take part in NCD prevention activities and youth-led health initiatives.

The Paonta Sahib site covers 14 acres and includes approximately 39,000 square metres of built-up manufacturing space.

Since its establishment, Sartorius Stedim Biotech has expanded the site through investments in infrastructure, production capacity, and employee training.